Our
Portfolio
GreenTech is at the forefront of advancing bio-active delivery characteristics through our innovative and patented ADDS platforms. We are committed to disrupting various industries where we believe our offerings address the lack of innovation in often overlooked market opportunities with global impact. Our strategy involves pursuing an integrated glide path to commercial viability, fostered by enduring and sustainable regional partnerships established through three (3) decades of expertise in the tier one
pharmaceutical and R&D landscapes . Throughout this journey, we remain cognisant of the inevitable challenges associated with introducing novel drugs and offerings to the market.
With our own unique international EU-GMP /cGMP and goto market lab footprint, we believe we are able to not only produce regionally to satisfy the new drive towards decentralised, post COVID production demands, but to ensure a high degree of collaboration in the regions we operate. This meticulous strategy supports grant funding for research, development and innovation stemming from our university, KOL's & partnership institutions.
Advanced Generics
Using bio-equivalence (or ANDA / 505 b2) routes to market, our repurposed ADDS technologies aim to improve drug performance characteristics in the following areas: WaferMat for ED, Migraine, HIV (Infants & Children) and Sleep (Circadian Rhythm Disorders).
Novel Candidates
GreenTech's Novel candidates entering gold standard, randomised
control Phase I/II trials in Denmark, SA, UK and UAE to FDA standards include: Sleep & Anxiety (Rx), Breakthrough Cancer Pain (BTcP), Acute Pain & Chronic Wounds (VLU/DFU)
Wellness & Anti - Ageing
Pharmaceutically and botanically repurposed ADDS's will drive true innovation in the areas of skin treatment and rejuvenation, both via topically and sublingually delivered offerings, for an effective and scientifically advanced composite solution found in our anti -ageing portfolio of products under final commercial roll out with strategic partner - Atzaro Clinique.
